Pdb59 - Cost-Effectiveness of Switching to Insulin Degludec (Ideg) U100 From Currently Available Basal Insulins in Belgium Based on Evidence From Real-World Clinical Practice

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.764
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search